Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.298,45
0,53%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Fusion Pharmaceuticals Inc (FUSN) Fusion Pharmaceuticals Inc (FUSN) Notizie

Fusion Pharmaceuticals Inc

FUSN
21,55
0,00 (0,00%)
22 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/6/202412:05EDGAR2Form 15-12G - Securities registration termination [Section..
10/6/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
04/6/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:39EDGAR2Form POS AM - Post-Effective amendments for registration..
04/6/202422:32EDGAR2Form S-8 POS - Securities to be offered to employees in..
04/6/202422:18EDGAR2Form 8-K - Current report
04/6/202422:05PRNUSAcquisition of Fusion Pharmaceuticals Completed
31/5/202422:12EDGAR2Form 8-K - Current report
31/5/202422:05PRNCAFusion Pharmaceuticals Receives Final Court Order Approving..
29/5/202422:34EDGAR2Form 8-K - Current report
29/5/202422:05PRNUSFusion Pharmaceuticals Shareholders Approve Acquisition by..
10/5/202422:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/5/202413:54EDGAR2Form 8-K - Current report
09/5/202422:14PRNUSFusion Pharmaceuticals Announces First Patient Dosed in the..
07/5/202414:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:30EDGAR2Form 8-K - Current report
07/5/202413:00PRNUSFusion Pharmaceuticals Reports First Quarter 2024 Financial..
26/4/202419:56PRNUSKuehn Law Encourages HCP, IP, SLCA, and FUSN Investors to..
25/4/202422:34PRNUSFusion Pharmaceuticals Mails Circular for Special Meeting of..
09/4/202422:05PRNCAFusion Pharmaceuticals Announces Presentation of Interim..
20/3/202421:10PRNUSKuehn Law Encourages DRQ, EVBG, FREE, and FUSN Investors to..
20/3/202421:05PRNCAFusion Pharmaceuticals Reports Fourth Quarter and Full Year..
19/3/202408:00PRNUSFusion Pharmaceuticals to be Acquired by AstraZeneca,..
06/3/202413:45PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
05/3/202422:43PRNUSFusion Pharmaceuticals to Present Interim Data from the..
26/2/202413:45PRNCAFusion Pharmaceuticals to Present at Upcoming March Investor..
16/2/202422:05EDGAR2Form 8-K - Current report
16/2/202414:45PRNUSFusion Pharmaceuticals Enters into Exclusive Worldwide..
07/2/202413:45PRNUSFusion Pharmaceuticals to Present at the Oppenheimer 34th..
06/2/202422:45PRNCAFusion Pharmaceuticals Announces Inducement Grants Under..
19/1/202422:13EDGAR2Form 8-K - Current report
19/1/202422:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/1/202414:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202414:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202414:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202414:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202412:14IHMARKETNEWSWall Street Highlights: Google Rejects Union Negotiations,..
05/1/202400:53DJNShares of Fusion Pharmaceuticals Rise 7.8% With Study..
04/1/202422:31EDGAR2Form 8-K - Current report
04/1/202422:05PRNCAFusion Pharmaceuticals Announces Clinical Program and..
Apertura: Min: Max:
Chiusura: 21,55

La tua Cronologia

NASDAQ
FUSN
Fusion Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network